PRFX Stocktwits, News and Mentions. Forecasting PainReform Ltd. Sentiments







Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…

PRFX Stock News and Mentions of PainReform Ltd. Stocktwits

Updated: April 29, 2024 (10:08)

Sector: Healthcare

Welcome to PandaPulse, innovative analytical stock market observer, where the latest news and stocktwits meets in-depth investor relations insights. Dive into our real-time sentiment analysis to gauge the mood of the markets and arm yourself with key information that resonates with both savvy investors and casual traders.

We meticulously analyze the sentiment trend in each article for the last 60 days where PainReform Company is mentioned. We assess its relevance and importance to carry out an overall sentiment valuation of PainReform Ltd. (PRFX).

You can view the trend designation for each individual article below. We use this data to compile indicators into one comprehensive sentiment value, which represents the current information agenda about the PainReform stocks.


Please wait, while the data is preparing...
General evaluation of the current information agenda's sentiments
Agenda Trend
Analyzed articles

News and Mentions of PainReform Ltd. (PRFX)

April 18, 2024 (18:19) / "GlobeNewswire" (by PainReform Ltd)

PainReform Announces Closing of $4 Million Public Offering

TEL AVIV, Israel, April 18, 2024 ( GLOBE NEWSWIRE ) -- PainReform Ltd. ( Nasdaq: PRFX ) ( "PainReform" or the "Company" ) , a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced the closing of its previously announced public ...
In Article Trend: Somewhat-Bullish
April 10, 2024 (18:07) / "Benzinga" (by Avi Kapoor)

Why Ascent Solar Technologies Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session - Ascent Solar Technologies ( NASDAQ:ASTI )

Shares of Ascent Solar Technologies, Inc. ASTI fell sharply during Wednesday's session after the company announced pricing of a $6 million public offering of shares at $0.14 per share. Ascent Solar Technologies shares dipped 50% to $0.1374 on Wednesday. Here are some other stocks moving in ...
In Article Trend: Neutral
April 10, 2024 (12:12) / "Benzinga" (by Avi Kapoor)

Why PriceSmart Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket - Pricesmart ( NASDAQ:PSMT )

Shares of PriceSmart, Inc. PSMT rose sharply in today's pre-market trading as the company posted better-than-expected earnings for its second quarter. The company reported quarterly earnings of $1.31 per share, beating market estimates of $1.25 per share.
In Article Trend: Neutral
April 9, 2024 (12:30) / "Benzinga" (by Vandana Singh)

EXCLUSIVE: PainReform's Non-Opiate Post-Surgical Pain Relief Treatment Outperforms Rival Medicine Under Various Testing Conditions - PainReform ( NASDAQ:PRFX )

PainReform Ltd PRFX announced results from new studies demonstrating the superior in-vitro release ( IVR ) rates of PRF-110 compared to topical post-surgical pain management products available in the market.
In Article Trend: Somewhat-Bullish
April 2, 2024 (12:00) / "Benzinga" (by Vandana Singh)

EXCLUSIVE: PainReform Reaches 50% Enrollment Target For Phase 3 Study For Its Lead Postoperative Pain Drug - PainReform ( NASDAQ:PRFX )

On Tuesday, PainReform Ltd PRFX announced it reached the 50% enrollment target for the second part of the Phase 3 clinical trial of PRF-110 in bunionectomy. A bunion is a bony bump that forms at the base of the big toe, forming a union with a foot bone called the first metatarsal.
In Article Trend: Neutral
March 1, 2024 (13:00) / "GlobeNewswire" (by PainReform Ltd)

PainReform Provides Year-End Business Update

Reports continued enrollment in the second part of the Phase 3 clinical trial in ...
In Article Trend: Somewhat-Bullish



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.